Read + Share
Frey C, Etminan M. Disproportionality analysis of BRAF and MEK inhibitors demonstrate risk of
retinal detachment: an analysis of the FDA Adverse Event Reporting System. Can J Ophthalmol 2025 Mar 26:S0008-4182(25)00117.
PMID: 40157389
|
 |
|
Frey C, Etminan M. Disproportionality analysis of BRAF and MEK inhibitors demonstrate risk of
retinal detachment: an analysis of the FDA Adverse Event Reporting System. Can J Ophthalmol 2025 Mar 26:S0008-4182(25)00117.
PMID: 40157389
|
|
|
|